202 related articles for article (PubMed ID: 36418517)
1. The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development.
Aljohani AI; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2023 Apr; 198(3):423-435. PubMed ID: 36418517
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of Cyclin B2 (
Aljohani AI; Toss MS; El-Sharawy KA; Mirza S; Ball GR; Green AR; Rakha EA
Am J Cancer Res; 2022; 12(2):469-489. PubMed ID: 35261781
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer.
Aljohani AI; Toss MS; Kurozumi S; Joseph C; Aleskandarany MA; Miligy IM; Ansari RE; Mongan NP; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jan; 179(1):79-90. PubMed ID: 31599393
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer.
Kariri YA; Alsaleem M; Joseph C; Alsaeed S; Aljohani A; Shiino S; Mohammed OJ; Toss MS; Green AR; Rakha EA
Breast Cancer Res Treat; 2021 Jan; 185(2):293-305. PubMed ID: 33073304
[TBL] [Abstract][Full Text] [Related]
5. The expression of high mobility group protein 3 (
Aljohani AI; Alsaeed SA; Toss MS; Raafat SA; Green AR; Rakha EA
Am J Cancer Res; 2023; 13(11):5334-5351. PubMed ID: 38058796
[TBL] [Abstract][Full Text] [Related]
6. Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer.
Aleskandarany MA; Sonbul S; Surridge R; Mukherjee A; Caldas C; Diez-Rodriguez M; Ashankyty I; Albrahim KI; Elmouna AM; Aneja R; Martin SG; Ellis IO; Green AR; Rakha EA
Br J Cancer; 2017 Oct; 117(8):1176-1184. PubMed ID: 28829761
[TBL] [Abstract][Full Text] [Related]
7. A key genomic subtype associated with lymphovascular invasion in invasive breast cancer.
Kurozumi S; Joseph C; Sonbul S; Alsaeed S; Kariri Y; Aljohani A; Raafat S; Alsaleem M; Ogden A; Johnston SJ; Aleskandarany MA; Fujii T; Shirabe K; Caldas C; Ashankyty I; Dalton L; Ellis IO; Desmedt C; Green AR; Mongan NP; Rakha EA
Br J Cancer; 2019 Jun; 120(12):1129-1136. PubMed ID: 31114020
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer.
Joseph C; Arshad M; Kurozomi S; Althobiti M; Miligy IM; Al-Izzi S; Toss MS; Goh FQ; Johnston SJ; Martin SG; Ellis IO; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2019 Apr; 174(2):387-399. PubMed ID: 30554343
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer.
Kariri YA; Joseph C; Kurozumi S; Toss MS; Alsaleem M; Raafat S; Mongan NP; Aleskandarany MA; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jan; 179(2):349-357. PubMed ID: 31679074
[TBL] [Abstract][Full Text] [Related]
10. Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer.
Aleskandarany MA; Sonbul SN; Mukherjee A; Rakha EA
Pathobiology; 2015 Sep; 82(3-4):113-23. PubMed ID: 26330352
[TBL] [Abstract][Full Text] [Related]
11. Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis.
Kurozumi S; Joseph C; Sonbul S; Gorringe KL; Pigera M; Aleskandarany MA; Diez-Rodriguez M; Nolan CC; Fujii T; Shirabe K; Kuwano H; Storr S; Martin SG; Ellis IO; Green AR; Rakha EA
Breast Cancer Res Treat; 2018 Aug; 170(3):525-533. PubMed ID: 29633055
[TBL] [Abstract][Full Text] [Related]
12. Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer.
Aljohani AI; Joseph C; Kurozumi S; Mohammed OJ; Miligy IM; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jun; 181(3):541-551. PubMed ID: 32350677
[TBL] [Abstract][Full Text] [Related]
13. Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival.
Joseph C; Alsaleem M; Orah N; Narasimha PL; Miligy IM; Kurozumi S; Ellis IO; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2020 Jul; 182(2):267-282. PubMed ID: 32445177
[TBL] [Abstract][Full Text] [Related]
14. Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.
Hamy AS; Lam GT; Laas E; Darrigues L; Balezeau T; Guerin J; Livartowski A; Sadacca B; Pierga JY; Vincent-Salomon A; Coussy F; Becette V; Bonsang-Kitzis H; Rouzier R; Feron JG; Benchimol G; Laé M; Reyal F
Breast Cancer Res Treat; 2018 Jun; 169(2):295-304. PubMed ID: 29374852
[TBL] [Abstract][Full Text] [Related]
15. Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis.
Wang C; Xie X; Li W; Jiang D
J Clin Lab Anal; 2022 Sep; 36(9):e24647. PubMed ID: 35949045
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer.
Kariri Y; Toss MS; Alsaleem M; Elsharawy KA; Joseph C; Mongan NP; Green AR; Rakha EA
Breast Cancer Res Treat; 2022 Apr; 192(3):529-539. PubMed ID: 35124721
[TBL] [Abstract][Full Text] [Related]
17. Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion.
Sonbul SN; Aleskandarany MA; Kurozumi S; Joseph C; Toss MS; Diez-Rodriguez M; Nolan CC; Mukherjee A; Martin S; Caldas C; Ellis IO; Green AR; Rakha EA
Mod Pathol; 2018 Nov; 31(11):1675-1682. PubMed ID: 29955149
[TBL] [Abstract][Full Text] [Related]
18. High expression of CCNB1 driven by ncRNAs is associated with a poor prognosis and tumor immune infiltration in breast cancer.
Fu H; Li K; Wang S; Li Y
Aging (Albany NY); 2022 Aug; 14(16):6780-6795. PubMed ID: 36040381
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of heat shock protein 90AA1 (HSP90α) in invasive breast cancer.
Alsaeed SA; Toss M; Alsaleem M; Aleskandarany M; Joseph C; Kurozumi S; Ball G; Mongan N; Green A; Rakha E
J Clin Pathol; 2022 Apr; 75(4):263-269. PubMed ID: 33766957
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of lymphovascular invasion in invasive breast carcinoma.
Rakha EA; Martin S; Lee AH; Morgan D; Pharoah PD; Hodi Z; Macmillan D; Ellis IO
Cancer; 2012 Aug; 118(15):3670-80. PubMed ID: 22180017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
